Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Boehringer, Forma Strike Discovery Deal In Oncology

Jan 06 2012

• By Paul Bonanos

Related Content

The Allure Of High-Hanging Fruit: Why VCs and Biotech Execs See Value In Difficult Drug Targets

Dec 01 2010

Genentech Licenses A Cancer Metabolism Program From Forma, With Option To Buy

Jun 27 2011

Forma To Play To Its Strengths WIth Genentech Deal

Jul 01 2011

Lilly, Novartis Help Forma Therapeutics Raise $25 Million To Expand R&D In Asia

Dec 21 2009

Related Companies

Forma Therapeutics Inc.

Genentech, Inc.

Boehringer Ingelheim GmbH

Eisai Co., Ltd.

Cubist Pharmaceuticals, Inc.

Novartis AG

Additional Topics

United States Germany Europe Deals BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window